Author:
Daniels Jonathan M.,Nestmann Earle R.,Kerr Alex
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug guides,Pharmacology (nursing)
Reference10 articles.
1. Witte D, Ensing K, Franke J-P, De Zeeuw R. Development and registration of chiral drugs. Pharm World Sci. 1993;15:10–16.
2. Shindo H, Caldwell J. Development of chiral drugs in Japan: an update on regulatory and industrial opinion. Chirality. 1995;7:349–352.
3. Guidelines on the development of stereoisomeric drugs (draft). Health Protection Branch Working Group on Drug Stereochemistry, Health and Welfare Canada; December 1993.
4. Guidelines for conduct and analysis of bioavailability and bioequivalence studies. Part A. Health Protection Branch, Health and Welfare Canada; 1992.
5. Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances. U.S. Food and Drug Administration, Center for Drugs and Biologies; February 1987.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献